Total Payments
$3,114
2024 Payments
$1,661
Companies
12
Transactions
65
Medicare Patients
959
Medicare Billing
$55,993
Payment Breakdown by Category
Food & Beverage$3,114 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,114 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | $1,576 | 21 | $0 (2024) |
| ABBVIE INC. | $319.94 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $265.33 | 10 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $240.00 | 2 | $0 (2022) |
| Allergan, Inc. | $224.90 | 5 | $0 (2022) |
| AngioDynamics, Inc. | $204.36 | 3 | $0 (2022) |
| Smith+Nephew, Inc. | $98.43 | 1 | $0 (2021) |
| Silk Road Medical, Inc. | $73.03 | 3 | $0 (2022) |
| Novo Nordisk Inc | $52.47 | 3 | $0 (2024) |
| Endologix LLC | $26.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,661 | 25 | REVANCE THERAPEUTICS, INC. ($1,576) |
| 2023 | $243.48 | 10 | ABBVIE INC. ($211.40) |
| 2022 | $696.40 | 20 | W. L. Gore & Associates, Inc. ($240.00) |
| 2021 | $512.80 | 10 | AngioDynamics, Inc. ($188.86) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $75.17 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $91.81 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $142.86 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $79.21 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $78.90 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/23/2024 | REVANCE THERAPEUTICS, INC. | DAXI (Drug) | Food and Beverage | In-kind items and services | $136.05 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/10/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $57.69 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $81.56 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $84.22 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $82.36 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $51.35 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/24/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $99.90 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/03/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $58.53 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/17/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $104.45 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $95.56 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Obesity | ||||||
| 03/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $44.56 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 03/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Obesity | ||||||
| 03/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $60.17 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $62.81 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 321 | 341 | $72,600 | $22,273 |
| 2021 | 4 | 245 | 269 | $48,803 | $16,363 |
| 2020 | 8 | 393 | 405 | $52,366 | $17,356 |
Total Patients
959
Total Services
1,015
Medicare Billing
$55,993
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 145 | $25,375 | $7,520 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $15,750 | $5,421 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 78 | 78 | $16,770 | $4,847 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 53 | $13,055 | $4,015 | 30.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,650 | $470.42 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 150 | $21,993 | $7,963 | 36.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 77 | 77 | $16,320 | $5,068 | 31.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 26 | $5,515 | $1,773 | 32.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $4,975 | $1,560 | 31.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 141 | 152 | $20,064 | $7,138 | 35.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 82 | 82 | $17,220 | $5,428 | 31.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 32 | $6,400 | $2,286 | 35.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $5,580 | $1,995 | 35.8% |
| 82565 | Blood creatinine level | Office | 2020 | 32 | 32 | $896.00 | $162.74 | 18.2% |
| 84520 | Urea nitrogen level to assess kidney function | Office | 2020 | 32 | 32 | $768.00 | $125.52 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 41 | 41 | $830.25 | $122.10 | 14.7% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 16 | 16 | $608.00 | $98.48 | 16.2% |
About Miranda Baugh, CFNP
Miranda Baugh, CFNP is a Family healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548246630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Miranda Baugh, CFNP has received a total of $3,114 in payments from pharmaceutical and medical device companies, with $1,661 received in 2024. These payments were reported across 65 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,114).
As a Medicare-enrolled provider, Baugh has provided services to 959 Medicare beneficiaries, totaling 1,015 services with total Medicare billing of $55,993. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family, Nurse Practitioner
- Location Texarkana, TX
- Active Since 12/20/2005
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1548246630
Products in Payments
- DAXXIFY (Drug) $1,440
- BOTOX (Biological) $310.81
- EXCLUDER Conformable AAA Endoprosthesis with Active Control (Device) $240.00
- XARELTO (Drug) $239.79
- DAXI (Drug) $136.05
- Auryon Laser System 100-120 Vac (Device) $134.14
- UBRELVY (Drug) $103.49
- COLLAGENASE SANTYL (Drug) $98.43
- QULIPTA (Drug) $55.44
- VenaCure 1470 Pro (Device) $54.72
- Wegovy (Drug) $52.47
- ENHANCE Transcarotid Peripheral Access Kit (Device) $26.93
- Alto Abdominal Stent Graft System (Device) $26.71
- SPRAVATO (Drug) $25.54
- ENROUTE Transcarotid Neuroprotection System (Device) $24.44
- ENROUTE .014 Guidewire (Device) $21.66
- MOUNJARO (Drug) $17.21
- KerraCel Ag (Device) $15.77
- AURYON LASER SYSTEM 100-120 VAC (Device) $15.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Texarkana
Mr. George Burgess, Rn,Fnp, RN,FNP
Family — Payments: $10,273
Family $10,273
Mrs. Kaleigh Foster, Fnp-C, FNP-C
Family — Payments: $6,177
Family $6,177
Virginia Parker, Fnp, FNP
Family — Payments: $5,740
Family $5,740
Dawn Strain, Fnp, FNP
Family — Payments: $4,438
Family $4,438
Larry Allen, Fnp, FNP
Family — Payments: $4,367
Family $4,367
Samuel Nix, Fnp, FNP
Family — Payments: $4,124
Family $4,124